Form 4: NewAmsterdam Pharma Co N.V. Executive Louise Kooij Reports Transaction in Ordinary Shares
SEC Form 4 Filing
Louise Kooij, Chief Accounting Officer of NewAmsterdam Pharma Co N.V., reports the acquisition and disposition of ordinary shares and derivative securities.
Summary
- On March 4, 2025, Louise Kooij, the Chief Accounting Officer of NewAmsterdam Pharma Co N.V., reported transactions involving the company's ordinary shares.
- Kooij acquired 150,000 ordinary shares through the exercise of an option.
- Simultaneously, Kooij disposed of 150,000 ordinary shares at a price of $20.37 per share.
- Following these transactions, Kooij directly owns 15,000 ordinary shares.
- Kooij also reported holding 18,073 derivative securities (options) exercisable for ordinary shares.
- The option was granted on November 22, 2022, replacing a previous option from July 6, 2021, with an exercise price of EUR 1.16392.
- 60,879 of the shares underlying the option immediately vested on the grant date, with the remaining shares vesting over three years.
Sentiment
Score: 5
Explanation: This is a neutral report of transactions. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
This filing is a routine disclosure related to insider trading activity, which is common for publicly traded companies. It provides transparency into the transactions of company executives.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding executive stock ownership.
- The sale of shares may have a minor impact on the stock price.
Key Dates
| Date | Description |
|---|---|
| 2021-07-06 | Original option grant date (later cancelled). |
| 2022-11-22 | Option granted to replace the original option. |
| 2025-03-04 | Date of transaction (acquisition and disposition of shares). |
| 2025-03-05 | Date of signature on the Form 4. |
| 2031-07-06 | Expiration date of the option. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.